NEW YORK (GenomeWeb News) – GATC Biotech and Complete Genomics said today that they are collaborating to sequence several human genomes from samples provided by GATC.
Under the agreement, Mountain View, Calif.-based Complete Genomics will sequence and assemble the genomes and provide GATC with detected variants including single nucleotide polymorphisms and indels.
GATC, based in Konstanz, Germany, will then perform bioinformatics analyses such as comparing the variant data of different genomes; and will refine the data with the intent of providing researchers and clinicians with relevant genomic details to advance their understanding of the genetic causes of diseases.
"To achieve our 100-Human-Genome-Project goal, evaluating Complete Genomics' human genome sequencing technology is a logical step," Peter Pohl, CEO of GATC Biotech, said in a statement.
Financial terms of the agreement were not disclosed.